Concourse Financial Group Securities, Inc. Rani Therapeutics Holdings, Inc. Put Options Transaction History
Concourse Financial Group Securities, Inc.
- $1.67 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding RANI
# of Institutions
47Shares Held
3.68MCall Options Held
44KPut Options Held
193K-
Vanguard Group Inc Valley Forge, PA710KShares$1.05 Million0.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$730,5040.67% of portfolio
-
Alphabet Inc. Mountain View, CA448KShares$663,7680.04% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$448,0590.01% of portfolio
-
Two Sigma Investments, LP New York, NY291KShares$431,2430.0% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $36.2M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...